HomeBUSINESS
BUSINESS

Kaketsuken Mum on Reported Biz Transfer to Kumamoto Consortium-Led Firm
(Oct.20.2017)

The Chemo-Sero-Therapeutic Research Institute, better known as Kaketsuken, on October 19 declined to comment on media reports that it plans to transfer its business to an entity to be newly formed by a company consortium in its home prefecture of Kumamoto and a major drug maker, possibly Meiji Seika Pharma ...
(LOG IN FOR FULL STORY)

News Calendar